Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep;49(9):6098-6109.
doi: 10.1002/mp.15824. Epub 2022 Jul 6.

Effect of boron compounds on the biological effectiveness of proton therapy

Mandira Manandhar  1 , Scott J Bright  1 , David B Flint  1 , David K J Martinus  1   2 , Rishab V Kolachina  1   3 , Mariam Ben Kacem  1 , Uwe Titt  1 , Tioga J Martin  4 , Chad L Lee  4 , Kendall Morrison  4 , Simona F Shaitelman  5 , Gabriel O Sawakuchi  1   2
Affiliations

Effect of boron compounds on the biological effectiveness of proton therapy

Mandira Manandhar et al. Med Phys. 2022 Sep.

Abstract

Purpose: We assessed whether adding sodium borocaptate (BSH) or 4-borono-l-phenylalanine (BPA) to cells irradiated with proton beams influenced the biological effectiveness of those beams against prostate cancer cells to investigate if the alpha particles generated through proton-boron nuclear reactions would be sufficient to enhance the biological effectiveness of the proton beams.

Methods: We measured clonogenic survival in DU145 cells treated with 80.4-ppm BSH or 86.9-ppm BPA, or their respective vehicles, after irradiation with 6-MV X-rays, 1.2-keV/μm (low linear energy transfer [LET]) protons, or 9.9-keV/μm (high-LET) protons. We also measured γH2AX and 53BP1 foci in treated cells at 1 and 24 h after irradiation with the same conditions.

Results: We found that BSH radiosensitized DU145 cells across all radiation types. However, no difference was found in relative radiosensitization, characterized by the sensitization enhancement ratio or the relative biological effectiveness, for vehicle- versus BSH-treated cells. No differences were found in numbers of γH2AX or 53BP1 foci or γH2AX/53BP1 colocalized foci for vehicle- versus BSH-treated cells across radiation types. BPA did not radiosensitize DU145 cells nor induced any significant differences when comparing vehicle- versus BPA-treated cells for clonogenic cell survival or γH2AX and 53BP1 foci or γH2AX/53BP1 colocalized foci.

Conclusions: Treatment with 11 B, at concentrations of 80.4 ppm from BSH or 86.9 ppm from BPA, had no effect on the biological effectiveness of proton beams in DU145 prostate cancer cells. Our results agree with published theoretical calculations indicating that the contribution of alpha particles from such reactions to the total absorbed dose and biological effectiveness is negligible. We also found that BSH radiosensitized DU145 cells to X-rays, low-LET protons, and high-LET protons but that the radiosensitization was not related to DNA damage.

Keywords: alpha particles; proton-boron capture therapy; proton-boron nuclear reaction; relative biological effectiveness; sensitization enhancement ratio.

PubMed Disclaimer

References

REFERENCES

    1. Yoon D-K, Jung J-Y, Suh TS. Application of proton boron fusion reaction to radiation therapy: a Monte Carlo simulation study. Appl Phys Lett. 2014;105(22):223507.
    1. Jung J-Y, Yoon D-K, Barraclough B, Lee HC, Suh TS, Lu B. Comparison between proton boron fusion therapy (PBFT) and boron neutron capture therapy (BNCT): a Monte Carlo study. Oncotarget. 2017;8(24):39774-39781.
    1. Kim M-S, Law MW-M, Djeng S-K, et al. Synergy effect of alpha particles by using natural boron in proton therapy: computational verification. AIP Adv. 2019;9(11):115017.
    1. Bláha P, Feoli C, Agosteo S, et al. The proton-boron reaction increases the radiobiological effectiveness of clinical low- and high-energy proton beams: novel experimental evidence and perspectives. Front Oncol. 2021;11(2122):682647.
    1. Cirrone GAP, Manti L, Margarone D, et al. First experimental proof of proton boron capture therapy (PBCT) to enhance proton therapy effectiveness. Sci Rep. 2018;8(1):1141.

LinkOut - more resources